Today Integra Lifesciences Holdings (IART) Hits New Lifetime High

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Integra Lifesciences Holdings ( IART) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Integra Lifesciences Holdings as such a stock due to the following factors:

  • IART has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $10.4 million.
  • IART has traded 15,008 shares today.
  • IART is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in IART with the Ticky from Trade-Ideas. See the FREE profile for IART NOW at Trade-Ideas

More details on IART:

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neurosurgery; U.S. Extremities; U.S. IART has a PE ratio of 59.9. Currently there are 6 analysts that rate Integra Lifesciences Holdings a buy, no analysts rate it a sell, and 7 rate it a hold.

The average volume for Integra Lifesciences Holdings has been 164,100 shares per day over the past 30 days. Integra Lifesciences has a market cap of $2.0 billion and is part of the health care sector and health services industry. The stock has a beta of 0.72 and a short float of 12% with 15.59 days to cover. Shares are up 13.7% year-to-date as of the close of trading on Wednesday.

If you liked this article you might like

Johnson & Johnson Signals It Could Make Additional Divestitures

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra Scoops up JNJ's Codman Neurosurgery for $1.05 Billion

Integra Scoops Up JNJ's Codman Neurosurgery for $1.05 Billion

Derma Sciences Soars Almost 40% on Buyout by Integra